Why the study?
Does low-dose indapamide (0.5-1.0 mg daily) normalize blood pressure in ambulatory patients with mild essential hypertension?
Does low-dose indapamide (0.5-1.0 mg daily) normalize blood pressure in ambulatory patients with mild essential hypertension?
Low doses of indapamide (0.5-1.0 mg daily) are insufficient to normalize blood pressure in most patients with mild essential hypertension.
Answers are grounded in this paper and cite their sources.
Low-dose indapamide rarely normalized BP in this cohort; leaves open whether titration or alternatives are needed in mild hypertension.
SummaryA dose-titration study was performed to assess the minimal antihypertensive dose of indapamide and the dose-response curve in ambulatory patients with mild essential hypertension (diastolic blood pressure 90 to 114 mmHg). After a 30-day placebo period, patients received 0.5 mg indapamide daily for 6 weeks and this was increased to 1.0 mg daily for a further 6 weeks in those not responding, i.e. with a standing diastolic pressure greater than 90 mmHg. Although indapamide demonstrated an antihypertensive effect at these dose levels, normalization of blood pressure was achieved in only 2 of the 13 patients on 0.5 mg per day and in none of the 11 patients receiving 1.0 mg per day. No clinical side-effects or abnormalities in serum potassium and uric acid were noted.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: